Astellas Ups Ante In $3.5B Hostile Bid For OSI
Japanese pharmaceutical giant Astellas Pharma Inc. has taken a guns-blazing approach to its $3.5 billion hostile takeover bid for OSI Pharmaceuticals Inc., launching a lawsuit accusing the Melville, N.Y.-based company and...To view the full article, register now.
Already a subscriber? Click here to view full article